Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 9-1 (MIR9-1) is a non-coding RNA gene that produces miR-9, a highly conserved microRNA controlling gene expression at the post-transcriptional level by binding to target mRNAs and modulating their translation and stability[3]. MIR9-1, highly expressed in neural progenitor cells, governs neuronal differentiation, migration, and apoptosis by targeting multiple mRNA transcripts. It plays context-dependent roles in cancer, acting both as a tumor suppressor (e.g., in medulloblastoma via epigenetic silencing) and as an oncogene in other cancers. Aberrant MIR9-1 regulation is also associated with neurodegenerative diseases. Its molecular function and involvement in disease make MIR9-1 a candidate for diagnostic biomarkers and a potential, though challenging, therapeutic target[1][2][3].
Mechanisms include modulation of miR-9-1 expression (re-expression, inhibition, or silencing) primarily via epigenetic regulation (e.g., CpG island hypermethylation reversal), miRNA mimics, and antisense inhibitors, which adjust post-transcriptional regulation of target mRNAs[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 9-1 (MIR9-1).